Reaction Details Report a problem with these data
Target
D(3) dopamine receptor
Ligand
BDBM476863
Substrate
n/a
Meas. Tech.
Binding Assay
Ki
0.200±n/a nM
Citation
 Tobinaga, H; Masuda, K; Inagaki, M; Yonehara, M; Masuda, M Nitrogen-containing condensed ring compounds having dopamine D3 antagonistic effect US Patent  US10870660 Publication Date 12/22/2020 
Target
Name:
D(3) dopamine receptor
Synonyms:
DOPAMINE D3 | DRD3 | DRD3_HUMAN | Dopamine D3 receptor | Dopamine D3 receptor (D3) | Dopamine D3 receptor (D3R) | Dopamine receptor | Dopamine receptor (D3) | Dopamine receptor D3
Type:
n/a
Mol. Mass.:
44243.43
Organism:
Homo sapiens (Human)
Description:
n/a
Residue:
400
Sequence:
MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC
  
Inhibitor
Name:
BDBM476863
Synonyms:
US10870660, Compound II-046 | US11345716, Compound II-087
Type:
Small organic molecule
Emp. Form.:
C26H32F3N5O2S
Mol. Mass.:
535.625
SMILES:
Cn1cc2c(cccc2n1)C(=O)N[C@H]1CC[C@H](CCN2CCc3nc(OCC(F)(F)F)sc3CC2)CC1 |r,wU:16.18,wD:13.14,(12.57,-.99,;11.8,.35,;10.27,.51,;9.95,2.02,;8.61,2.79,;8.61,4.33,;9.95,5.1,;11.28,4.33,;11.28,2.79,;12.42,1.76,;7.28,2.02,;7.28,.48,;5.94,2.79,;4.61,2.02,;3.28,2.79,;1.94,2.02,;1.94,.48,;.61,-.29,;-.72,.48,;-2.06,-.29,;-3.26,.67,;-4.76,.32,;-5.43,-1.06,;-6.96,-1.27,;-7.23,-2.79,;-8.57,-3.56,;-9.9,-2.79,;-11.23,-3.56,;-11.23,-5.1,;-12.57,-4.33,;-12.57,-2.79,;-5.88,-3.52,;-4.76,-2.45,;-3.26,-2.79,;-2.06,-1.83,;3.28,-.29,;4.61,.48,)|
Structure:
Search PDB for entries with ligand similarity: